OTCMKTS:MMEDF

Mind Medicine (MindMed) Competitors

$3.23

+0.24 (+8.03 %)

(As of 05/14/2021 12:00 AM ET)

Add

Compare

Today's Range

$3.06

▼

$3.33

50-Day Range

$2.13

▼

$4.69

52-Week Range

$0.29

▼

$5.07

Volume6.50 million shs

Average Volume3.38 million shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Mind Medicine (MindMed) (OTCMKTS:MMEDF) Vs. DDXS, TNGN, ATTBF, ADTX, AGNPF, and LBTSF

Should you be buying MMEDF stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Mind Medicine (MindMed), including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), ADiTx Therapeutics (ADTX), Algernon Pharmaceuticals (AGNPF), and Almirall (LBTSF).

Mind Medicine (MindMed) vs. (DDXS) Stock

Mind Medicine (MindMed) (OTCMKTS:MMEDF) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Valuation & Earnings

This table compares Mind Medicine (MindMed) and (DDXS)'s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mind Medicine (MindMed)	N/A	N/A	N/A	N/A	N/A
(DDXS)	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Mind Medicine (MindMed) and (DDXS)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mind Medicine (MindMed)	N/A	N/A	N/A
(DDXS)	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations for Mind Medicine (MindMed) and (DDXS), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mind Medicine (MindMed)	0	0	1	0	3.00
(DDXS)	0	0	0	0	N/A

Mind Medicine (MindMed) currently has a consensus target price of $2.00, indicating a potential downside of 38.08%. Given Mind Medicine (MindMed)'s higher possible upside, analysts clearly believe Mind Medicine (MindMed) is more favorable than (DDXS).

Summary

Mind Medicine (MindMed) beats (DDXS) on 2 of the 2 factors compared between the two stocks.

Mind Medicine (MindMed) vs. (TNGN) Stock

Mind Medicine (MindMed) (OTCMKTS:MMEDF) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Valuation & Earnings

This table compares Mind Medicine (MindMed) and (TNGN)'s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mind Medicine (MindMed)	N/A	N/A	N/A	N/A	N/A
(TNGN)	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Mind Medicine (MindMed) and (TNGN)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mind Medicine (MindMed)	N/A	N/A	N/A
(TNGN)	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations for Mind Medicine (MindMed) and (TNGN), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mind Medicine (MindMed)	0	0	1	0	3.00
(TNGN)	0	0	0	0	N/A

Mind Medicine (MindMed) currently has a consensus target price of $2.00, indicating a potential downside of 38.08%.

Summary

Mind Medicine (MindMed) beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Mind Medicine (MindMed) vs. Abattis Bioceuticals Stock

Mind Medicine (MindMed) (OTCMKTS:MMEDF) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Valuation & Earnings

This table compares Mind Medicine (MindMed) and Abattis Bioceuticals' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mind Medicine (MindMed)	N/A	N/A	N/A	N/A	N/A
Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Mind Medicine (MindMed) and Abattis Bioceuticals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mind Medicine (MindMed)	N/A	N/A	N/A
Abattis Bioceuticals	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations for Mind Medicine (MindMed) and Abattis Bioceuticals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mind Medicine (MindMed)	0	0	1	0	3.00
Abattis Bioceuticals	0	0	0	0	N/A

Summary

Mind Medicine (MindMed) beats Abattis Bioceuticals on 2 of the 2 factors compared between the two stocks.

Mind Medicine (MindMed) vs. ADiTx Therapeutics Stock

Mind Medicine (MindMed) (OTCMKTS:MMEDF) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Valuation & Earnings

This table compares Mind Medicine (MindMed) and ADiTx Therapeutics' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mind Medicine (MindMed)	N/A	N/A	N/A	N/A	N/A
ADiTx Therapeutics	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Mind Medicine (MindMed) and ADiTx Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mind Medicine (MindMed)	N/A	N/A	N/A
ADiTx Therapeutics	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations for Mind Medicine (MindMed) and ADiTx Therapeutics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mind Medicine (MindMed)	0	0	1	0	3.00
ADiTx Therapeutics	0	0	1	0	3.00

Summary

Mind Medicine (MindMed) beats ADiTx Therapeutics on 1 of the 1 factors compared between the two stocks.

Mind Medicine (MindMed) vs. Algernon Pharmaceuticals Stock

Mind Medicine (MindMed) (OTCMKTS:MMEDF) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Analyst Ratings

This is a breakdown of current recommendations for Mind Medicine (MindMed) and Algernon Pharmaceuticals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mind Medicine (MindMed)	0	0	1	0	3.00
Algernon Pharmaceuticals	0	0	0	0	N/A

Valuation & Earnings

This table compares Mind Medicine (MindMed) and Algernon Pharmaceuticals' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mind Medicine (MindMed)	N/A	N/A	N/A	N/A	N/A
Algernon Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Mind Medicine (MindMed) and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mind Medicine (MindMed)	N/A	N/A	N/A
Algernon Pharmaceuticals	N/A	N/A	N/A

Summary

Mind Medicine (MindMed) beats Algernon Pharmaceuticals on 2 of the 2 factors compared between the two stocks.

Mind Medicine (MindMed) vs. Almirall Stock

Almirall (OTCMKTS:LBTSF) and Mind Medicine (MindMed) (OTCMKTS:MMEDF) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and valuation.

Analyst Recommendations

This is a breakdown of current ratings for Almirall and Mind Medicine (MindMed), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Almirall	0	1	1	0	2.50
Mind Medicine (MindMed)	0	0	1	0	3.00

Mind Medicine (MindMed) has a consensus target price of $2.00, indicating a potential downside of 38.08%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher possible upside, analysts plainly believe Mind Medicine (MindMed) is more favorable than Almirall.

Earnings and Valuation

This table compares Almirall and Mind Medicine (MindMed)'s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Almirall	N/A	N/A	N/A	N/A	N/A
Mind Medicine (MindMed)	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Almirall and Mind Medicine (MindMed)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Almirall	N/A	N/A	N/A
Mind Medicine (MindMed)	N/A	N/A	N/A

Summary

Mind Medicine (MindMed) beats Almirall on 2 of the 2 factors compared between the two stocks.

Ad IPM

Legendary Crypto Analyst Names 3 Coins to Buy Instead of Coinbase

Matt McCall’s crypto portfolio has delivered multiple 1,000% winners in just months… Now he’s naming 3 tokens he believes folks should own instead of the Coinbase stock in a free report.